Release Date: 06/08/13 15:28 Summary: Non-Renounceable Rights Issue - Despatch of Prospectus Price Sensitive: No Download Document 93.56KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status